Boldt Joachim, Ducke Michael, Kumle Bernhard, Papsdorf Michael, Zurmeyer Ernst-Ludwig
Department of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67063 Ludwigshafen, Germany.
Intensive Care Med. 2004 Mar;30(3):416-22. doi: 10.1007/s00134-003-2110-7. Epub 2004 Jan 8.
Adequate restoration of intravascular volume remains an important maneuver in the management of the surgical patient. Influence of different volume replacement regimens on inflammation/endothelial activation in elderly surgical patients was assessed.
Prospective, randomized study.
Surgical intensive care unit of a university-affiliated hospital.
Sixty-six patients >65 years undergoing major abdominal surgery.
Ringer's lactate (RL; n=22), normal saline solution (NS; n=22) or a low-molecular HES (mean molecular weight 130 kD) with a low degree of substitution (0.4; HES 130/0.4; n=22) were administered after induction of anesthesia until the 1st postoperative day (POD) to keep central venous pressure between 8-12 mmHg.
C-reactive protein, interleukins (IL-6, IL-8), adhesion molecules [endothelial leukocyte adhesion molecule-1 (ELAM-1) and intercellular adhesion molecule-1 (ICAM-1)] were measured prior to volume therapy at the end of surgery, 5 h after surgery and at the morning of the 1st POD. RL patients received 10,150+/-1,660 ml of RL, NS patients 10,220+/-1,770 ml of NS and the HES-treated group 2,850+/-300 ml of HES 130/0.4 and 2,810+/-350 ml of RL. Hemodynamics were similar in all groups. CRP, IL-6 and IL-8 plasma levels increased significantly higher in both crystalloid groups (IL-6 in the NS group: increase to 407+/-33 pg/ml; RL: increase to 377+/-35 pg/dl) than in the HES-130 treated group (IL-6: increase to 197+/-20 pg/dl). Plasma levels of ELAM-1 and ICAM remained almost unchanged in the HES 130-, but significantly increased in the RL- and NS-treated patients.
In elderly patients, markers of inflammation and endothelial injury and activation were significantly higher after crystalloid- than after HES 130/0.4-based volume replacement regimens.
充分恢复血管内容量仍是外科患者管理中的一项重要措施。评估不同容量替代方案对老年外科患者炎症/内皮激活的影响。
前瞻性随机研究。
大学附属医院的外科重症监护病房。
66例年龄>65岁的接受腹部大手术的患者。
麻醉诱导后至术后第1天给予乳酸林格液(RL;n = 22)、生理盐水(NS;n = 22)或低分子羟乙基淀粉(平均分子量130 kD,取代度0.4;HES 130/0.4;n = 22),以维持中心静脉压在8 - 12 mmHg之间。
在容量治疗前、手术结束时、术后5小时和术后第1天上午测量C反应蛋白、白细胞介素(IL - 6、IL - 8)、黏附分子[内皮白细胞黏附分子 - 1(ELAM - 1)和细胞间黏附分子 - 1(ICAM - 1)]。RL组患者接受10150±1660 ml的RL,NS组患者接受10220±1770 ml的NS,羟乙基淀粉治疗组接受2850±300 ml的HES 130/0.4和2810±350 ml的RL。所有组的血流动力学相似。两个晶体液组的CRP、IL - 6和IL - 8血浆水平显著高于羟乙基淀粉130治疗组(NS组IL - 6:升至407±33 pg/ml;RL组:升至377±35 pg/dl)(羟乙基淀粉1治疗组IL - 6:升至197±20 pg/dl)。羟乙基淀粉130治疗组的ELAM - 1和ICAM血浆水平几乎保持不变,但RL组和NS组治疗的患者显著升高。
在老年患者中,基于晶体液的容量替代方案后炎症、内皮损伤和激活标志物显著高于基于羟乙基淀粉130/0.4的方案。